SEC Form 4 · accession 0001514346-16-000003
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Kathleen Bielasz
Officer — VP, Finance and Accounting
Period of report
Mar 2, 2016
Accepted (ET)
Mar 4, 2016 · 6:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.55 | Mar 2, 2016 | A | 252,000 | A | — | Mar 2, 2023 | Common Stock | 252,000 | 252,000 | D |
Explanation of responses
- F1The options vest in four equal annual installments beginning on March 2, 2017, and are exercisable once vested.